Innovative IV Catheter Receives FDA Clearance and Secures Funding from Washington Area Venture Capital Firm The Zitelman Group announced it has led a $600,000 Series B Preferred equity round for Israel-based medical device firm, Flexicath, Ltd. Flexicath received a 510(k) clearance from FDA in October, allowing it to place its FirmGrip sterile catheter intravenous (IV) system in the U.S market. The funding will be used to ramp-up U.S. and international sales and marketing for the FirmGrip catheter. [more...]
